Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HESTERBIO | NSE
-48.75
-1.99%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
18/09/2024
2,404.50
2,428.70
2,470.00
2,375.00
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases such as newcastle disease infectious bronchitis infectious bursal disease fowl pox egg drop syndrome reo marek's disease infectious coryza fowl cholera mycoplasma gallisepticum inclusion body hepatitis avian encephalomyelitis etc. It also offers vaccines for large animals comprising Goat Pox Peste des Petits Ruminants Brucellosis Mastitis Metritis and various infectious diseases as well as infections reproductive disorders theileriosis parasitic diseases etc. In addition the company provides feed supplements such as toxin binder trace minerals enzyme preparation and bypass fat; disinfectants for farms and equipment and water sanitizers; nutrition products consisting of mineral mixtures fertility supplements and growth tonics; and herbal products including growth promoters herbal replacers for choline chloride stress relievers and immunity boosters respiratory stimulants liver tonics wound healing preparations uterine tonics digestive tonics and anti-bloat solutions ectoparasiticide preparations anti-mastitis and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad India.
View LessLow Market Beta (-0.4 to 0.8)
Negative Momentum (Declining Price)
Price Below SMA10D
Microcap (<300M USD)
High Debt to Equity (> 0.75)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
31.1%1 month
31.9%3 months
68.9%6 months
57.3%104.10
-
6.87
0.84
0.37
36.66
7.49
-
637.49M
20.49B
245.02M
0.25
17.66
11.50
-6.20
7.16
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
308.10
Range1M
335.95
Range3M
1.34K
Rel. volume
0.26
Price X volume
5.29M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Syncom Formulations (India) Limited | SYNCOMF | Drug Manufacturers-Specialty & Generic | 23.18 | 22.16B | -2.85% | 83.97 | 25.16% |
Windlas Biotech Limited | WINDLAS | Drug Manufacturers-Specialty & Generic | 872.4 | 18.29B | -2.56% | 31.83 | 0.81% |
Lincoln Pharmaceuticals Ltd | LINCOLN | Drug Manufacturers-Specialty & Generic | 737 | 14.78B | -4.72% | 15.67 | 0.18% |
Bliss Gvs Pharma Limited | BLISSGVS | Drug Manufacturers-Specialty & Generic | 127.88 | 13.43B | -2.66% | 17.47 | 10.32% |
Nectar Lifesciences Limited | NECLIFE | Drug Manufacturers-Specialty & Generic | 46.62 | 10.75B | -2.59% | 201.62 | 59.44% |
Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | Drug Manufacturers-Specialty & Generic | 405.85 | 10.74B | -1.04% | 53.99 | 4.77% |
Bajaj HealthCare Limited | BAJAJHCARE | Drug Manufacturers-Specialty & Generic | 383.15 | 10.70B | -4.01% | n/a | 119.57% |
Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 1479.35 | 8.44B | -0.14% | 10.74 | 0.87% |
Wanbury Limited | WANBURY | Drug Manufacturers-Specialty & Generic | 253.35 | 8.30B | -1.11% | 16.51 | 416.89% |
Ind-Swift Laboratories Limited | INDSWFTLAB | Drug Manufacturers-Specialty & Generic | 137.79 | 8.14B | -1.82% | 2.10 | 1.78% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Bhagyanagar India Ltd | BHAGYANGR | Copper | 106.49 | 3.41B | -2.42% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 172.05 | 1.91B | 1.72% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 96.65 | 1.38B | -1.91% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.91 | 1.03B | -1.89% | n/a | 32.70% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.89 | 336.84M | -5.34% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 5.05 | 303.87M | -0.98% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 36.66 | - | Expensive |
Ent. to Revenue | 7.49 | - | Cheaper |
PE Ratio | 104.10 | 47.84 | Expensive |
Price to Book | 6.87 | 6.55 | Par |
Dividend Yield | 0.25 | - | Poor |
Std. Deviation (3M) | 68.89 | - | Riskier |
Debt to Equity | 0.84 | 0.34 | Expensive |
Debt to Assets | 0.37 | 0.17 | Expensive |
Market Cap | 20.49B | - | Emerging |